Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last --
Change Today 0.00 / 0.00%
Volume 0.0
526139 On Other Exchanges
526139 is not on other exchanges.
All times are local (Market data is delayed by at least 15 minutes).

transgene biotek ltd (526139) Snapshot

Previous Close
Day High
Day Low
52 Week High
-- - --
52 Week Low
-- - --
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for TRANSGENE BIOTEK LTD (526139)

Related News

No related news articles were found.

transgene biotek ltd (526139) Related Businessweek News

No Related Businessweek News Found

transgene biotek ltd (526139) Details

Transgene Biotek Limited, a biotechnology company, engages in the diagnostic services and trading of bulk drugs in India. Its product portfolio covers various areas, including oncology, auto-immunity, biogenerics, and drug delivery. The company was incorporated in 1990 and is based in Medak, India.

Founded in 1990

transgene biotek ltd (526139) Top Compensated Officers

Chairman, Managing Director, Compliance Offic...
Total Annual Compensation: 1.5M
Compensation as of Fiscal Year 2015.

transgene biotek ltd (526139) Key Developments

Transgene Biotek Ltd., Board Meeting, Aug 14, 2015

Transgene Biotek Ltd., Board Meeting, Aug 14, 2015. Agenda: To consider quarterly results.

Transgene Biotek Ltd Appoints K. Koteswara Rao as Compliance Officer

Transgene Biotek Ltd. announced that Dr. K. Koteswara Rao has been appointed as the new Compliance officer of the company with immediate effect.

Transgene Biotek Ltd., Board Meeting, May 30, 2015

Transgene Biotek Ltd., Board Meeting, May 30, 2015. Agenda: To consider audited results.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
TB:IN 2.86 INR 0.00

526139 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 526139.
View Industry Companies

Industry Analysis


Industry Average

Valuation 526139 Industry Range
Price/Earnings NM Not Meaningful
Price/Sales -- Not Meaningful
Price/Book -- Not Meaningful
Price/Cash Flow NM Not Meaningful
TEV/Sales -- Not Meaningful

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact TRANSGENE BIOTEK LTD, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at